top of page

The International Council for Standardization in Haematology (the ICSH) is pleased to welcome Dr Ben Hedley PhD to the Board.

Ben is a Medical Scientist with a distinguished career in laboratory haematology.


With a focus on standardization he brings his wealth of experience to the Board.


Ben has been involved with the ICSH for many years through his involvement in Project Working Groups.


He brings a wealth of experience and in particular to cellular analysis and flow cytometry.

We welcome Ben and look forward to his contributions to the ICSH.




January 2024


The International Council for Standardisation in Haematology (ICSH) is pleased to announce the publication of a new ICSH review of internal quality control policy for blood cell counters.


Contributors


Richard McCafferty  |  George Cembrowski  |  Barbara de la Salle  | Mingting Peng  |  Eloisa Urrechaga


Introduction


This paper is a report of an ICSH review of policies and practices for internal quality control (IQC) policy for haematology cell counters among regulatory bodies, cell counter manufacturers and diagnostic laboratories. It includes a discussion of the study findings and links to separate ICSH guidance for such policies and practices. The application of internal quality control (IQC) methods is an essential pre-requisite for all clinical laboratory testing including the blood count (Full Blood Count, FBC, or Complete Blood Count, CBC).


....continue reading at Wiley Online Library -



First published: 12 January 2024


The publication is available to:





January 2024


The International Council for Standardisation in Haematology is pleased to announce the publication of a new ICSH guidance for internal quality control policy for blood cell counters.


Contributors

Richard McCafferty  |  George Cembrowski  |  Barbara de la Salle  | Mingting Peng  |  Eloisa Urrechaga


Abstract: This paper is a description of the ICSH guidance for internal quality control (IQC)policy for blood cell counters. It follows from and links to a separate ICSH review for such policies and practices.


The ICSH has gathered information regarding the current state of practice through review of published guidance from regulatory bodies, a questionnaire to six major cell counter manufacturers and a survey issued to 191 diagnostic laboratories in four countries (China, the Republic of Ireland,Spain, and the United Kingdom) on their IQC practice and approach to the use of commercial IQC materials. This has revealed diversity both in guidance and in practice around the world. There is diversity in guidance from regulatory organizations in regard to IQC methods each recommends, clinical levels to use and frequency to run commercial controls, and finally recommended sources of commercial control materials.


The diversity in practice among clinical laboratories spans the areas of IQC methods used, derivation of target values, and action limits used with commercial control materials, and frequency of running commercial controls materials. These findings and their implications for IQC Practice are addressed in this guidance document, which proposes a harmonized approach to address the issues faced by diagnostic laboratories


....continue reading at Wiley Online Library - https://onlinelibrary.wiley.com/doi/epdf/10.1111/ijlh.14212


First published: January 2024


The publication is available to:



ISSN - 1751-5521

eISSN - 1751-553X



bottom of page